Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission

被引:11
|
作者
Mischnik, Alexander [1 ,2 ,11 ]
Baumert, Philipp [1 ,2 ]
Hamprecht, Axel [1 ,3 ]
Rohde, Anna [1 ,4 ]
Peter, Silke [1 ,5 ]
Feihl, Susanne [1 ,6 ]
Knobloch, Johannes [1 ,7 ]
Goelz, Hanna [1 ,8 ]
Kola, Axel [1 ,4 ]
Obermann, Birgit [1 ,9 ]
Querbach, Christiane [1 ,6 ]
Willmann, Matthias [1 ,5 ]
Gebhardt, Friedemann [1 ,6 ]
Tacconelli, Evelina [1 ,10 ]
Gastmeier, Petra [1 ]
Seifert, Harald [1 ]
Kern, Winfried V. [1 ,2 ]
机构
[1] German Ctr Infect Res DZIF, Hannover, Germany
[2] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany
[3] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany
[4] Chari Univ Hosp Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Inst Hyg & Environm Med, Berlin, Germany
[5] Univ Tubingen, Inst Med Microbiol & Hygiene, Tubingen, Germany
[6] Tech Univ Munich, Inst Med Microbiol Immunol & Hygiene, Munich, Germany
[7] Univ Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hygiene, Hamburg, Germany
[8] Univ Med Ctr Freiburg, Inst Med Microbiol & Hygiene, Freiburg, Germany
[9] Univ Hosp Schleswig Holstein, Inst Med Microbiol, Lubeck, Germany
[10] Univ Hosp Tubingen, Dept Internal Med 1, Div Infect Dis, Tubingen, Germany
[11] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Hugstetter Str 55, D-79106 Freiburg, Germany
关键词
Extended-spectrum beta-lactamase; ESBL; beta-Lactam; Avibactam; AmpC; IN-VITRO ACTIVITY; BETA-LACTAMASES; AVIBACTAM; COLONIZATION; CEFTAZIDIME; BACTEREMIA;
D O I
10.1016/j.ijantimicag.2016.10.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
As part of the multicentre Antibiotic Therapy Optimisation Study (ATHOS), minimum inhibitory concentrations (MICs) were determined for cephalosporins alone and in combination with the beta-lactamase inhibitors tazobactam, clavulanic acid and avibactam against third-generation cephalosporin-resistant Escherichia coli, Klebsiella spp. and Enterobacter spp. isolates collected in German hospitals. MIC50/90 values were 0.254mg/L for cefepime/tazobactam, 0.25-2 mg/L for ceftazidime/avibactam, 0.125-0.5mg/L for ceftaroline/avibactam, 0.5-4 mg/L for cefpodoxime/clavulanic acid and 0.25-1 mg/L for aztreonam/avibactam, depending on the underlying resistance mechanism and organism. Based on in vitro testing, beta-lactam antibiotics play an important role in the treatment of infections due to beta-lactamase-producing organisms. (C) 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 50 条
  • [1] Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
    Mischnik, Alexander
    Baumert, Philipp
    Hamprecht, Axel
    Rohde, Anna
    Peter, Silke
    Feihl, Susanne
    Knobloch, Johannes
    Goelz, Hanna
    Kola, Axel
    Obermann, Birgit
    Querbach, Christiane
    Willmann, Matthias
    Gebhardt, Friedemann
    Tacconelli, Evelina
    Gastmeier, Petra
    Seifert, Harald
    Kern, Winfried V.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (01) : 71 - 73
  • [2] Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospital
    Boldt, Anne-Catherine
    Schwab, Frank
    Rohde, Anna M.
    Kola, Axel
    Bui, Minh Trang
    Maertin, Nayana
    Kipnis, Marina
    Schroeder, Christin
    Leistner, Rasmus
    Wiese-Posselt, Miriam
    Zweigner, Janine
    Gastmeier, Petra
    Denkel, Luisa A.
    PLOS ONE, 2018, 13 (08):
  • [3] Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units
    Thiebaut, Anne C. M.
    Arlet, Guillaume
    Andremont, Antoine
    Papy, Emmanuelle
    Sollet, Jean-Pierre
    Bernede-Bauduin, Claire
    Guillemot, Didier
    Schlemmer, Benoit
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1525 - 1536
  • [4] Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia
    O'Neal, Catherine S.
    O'Neal, Hollis R.
    Daniels, Titus L.
    Talbot, Thomas R.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (10) : 726 - 732
  • [5] Risks and burdens of third-generation cephalosporin resistant Enterobacteriaceae in neonatal sepsis
    Thatrimontrichai, A.
    Premprat, N.
    Janjindamai, W.
    Dissaneevate, S.
    Maneenil, G.
    TROPICAL BIOMEDICINE, 2020, 37 (03) : 663 - 670
  • [6] Characterization of Third-Generation Cephalosporin-Resistant Escherichia coli from Bloodstream Infections in Denmark
    Hansen, Frank
    Olsen, Stefan S.
    Heltberg, Ole
    Justesen, Ulrik S.
    Fuglsang-Damgaard, David
    Knudsen, Jenny D.
    Hammerum, Anette M.
    MICROBIAL DRUG RESISTANCE, 2014, 20 (04) : 316 - 324
  • [7] Importance of pre-enrichment for detection of third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB) from rectal swabs
    Jazmati, N.
    Jazmati, T.
    Hamprecht, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (10) : 1847 - 1851
  • [8] Epidemiology and molecular characterization of fecal carriage of third-generation cephalosporin-resistant Enterobacterales among elderly residents in Japan
    Nakai, Miyuki
    Oka, Keisuke
    Watanabe, Genichi
    Kamei, Katsunori
    Tsukada, Norio
    Mori, Ryota
    Nagaya, Masahiro
    Ukai, Yasumitsu
    Morioka, Hiroshi
    Tetsuka, Nobuyuki
    Iguchi, Mitsutaka
    Yagi, Tetsuya
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (04) : 569 - 575
  • [9] Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae Complex in Germany
    Xanthopoulou, Kyriaki
    Imirzalioglu, Can
    Walker, Sarah, V
    Behnke, Michael
    Dinkelacker, Ariane G.
    Eisenbeis, Simone
    Gastmeier, Petra
    Goelz, Hanna
    Kaeding, Nadja
    Kern, Winfried, V
    Kola, Axel
    Kramme, Evelyn
    Lucassen, Kai
    Mischnik, Alexander
    Peter, Silke
    Rohde, Anna M.
    Rupp, Jan
    Tacconelli, Evelina
    Tobys, David
    Vehreschild, Maria J. G. T.
    Wille, Julia
    Seifert, Harald
    Higgins, Paul G.
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [10] Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study
    Cédric Dananché
    Thomas Bénet
    Bernard Allaouchiche
    Romain Hernu
    Laurent Argaud
    Olivier Dauwalder
    François Vandenesch
    Philippe Vanhems
    Critical Care, 19